![](http://admin.scimea.cn/public/cut_e/e2aca7692f1ceafb983979539048bfb7.jpg)
On the morning of March 28, 2021, the inaugural meeting of the Special Committee on Respiratory and Critical Care Medicine of Sichuan International Medical Exchange & Promotion Association (“SCIMEA”)
2021-04-06
![](http://admin.scimea.cn/public/cut_e/0ee35b546928bb363d6d033f5f46c812.jpg)
Irish health officials on Sunday recommended the temporary suspension of the AstraZeneca vaccine after reports of serious blood clotting after inoculations in Norway.
2021-03-29
![](http://admin.scimea.cn/public/cut_e/924cc9acd79d9f81b899364b191080ae.jpg)
On March 12, 2021, the inaugural meeting of the Special Committee on Heart Rhythm of Sichuan International Medical Exchange & Promotion Association (“SCIMEA”) was successfully held at the Renaissance ....
2021-03-26
![](http://admin.scimea.cn/public/cut_e/b08504ac694bb1c4e7a3370354db8129.jpg)
Now MedComm is privileged to have Prof. Günter P. Wagner, a U.S. Academician as an Editor-in-Chief.
2021-03-26
![](/static/enhome/images/icon-tag.png)
MedComm
![](http://admin.scimea.cn/public/cut_e/c9051a54fdbf734479d0998a5df9a7f7.jpg)
On the morning, a meeting was held at the Great Hall of the People to commend role models in the country's fight against the COVID-19 epidemic.
2021-03-19
![](http://admin.scimea.cn/public/cut_e/0f12a1e252222c3871dbb9c4621f9a35.jpg)
On November 19, 2020, the “West China-Mayo International Forum of Critical Care Medicine 2020”, hosted by Sichuan Preventive Medicine Association, Sichuan International Medical Exchange & Promotion As
2021-03-22
![](http://admin.scimea.cn/public/cut_e/310930af2726581304fdfcb583c7e5d9.jpg)
On December 10, the first Sichuan and Chongqing Science and Technology Academic Conference and Sichuan Science and Technology Academic Conference kicked off in Chengdu.
2021-03-22
![](http://admin.scimea.cn/public/cut_e/0b38ea37c5ccc6f4f3c48ef56d4b4129.jpg)
Chengdu High-Tech Zone, Shanghai Pharmaceuticals and Wesker sign an agreement to build Tianfu Vaccine Valley and create a full-chain vaccine industry
2021-03-19
![](http://admin.scimea.cn/public/cut_e/fdee85025764811bc8cc66e1e1ff43c9.jpg)
It is reported that the phase II clinical trial of the recombinant protein COVID-19 vaccine (Sf9 cell) from West China Hospital of Sichuan University/Chengdu Wesker Biomedical Co., Ltd.
2021-03-16